Spectral Med Inc faces a challenging trading day as its stock price takes a notable dip.
Spectral Med Inc (EDT.TO) is experiencing a downturn, with shares falling by 2.86% to close at CA$1.36. This decline comes amid limited news and ongoing market volatility, which raises concerns for investors.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeAdvertisement
Market cap
$407.85M
52W high
$1.84
52W low
$0.97
1W change
-1.42%
Beta
0.21
Analyst Price Targets
Based on analyst covering EDT
Wall Street analysts forecast EDT stock price to rise 126.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+126.6% Upside
Current Price
C$1.39
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
27.0%
Annualized
90-Day Vol
28.5%
Annualized
Trend (90d)
-6.0%
Annualized drift
90d Mean
C$1.36
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.38 | C$1.26 – C$1.51 |
| 60 trading days | C$1.37 | C$1.20 – C$1.56 |
| 90 trading days | C$1.36 | C$1.16 – C$1.60 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With no recent significant announcements or catalysts, investors should closely monitor the stock's performance and market conditions before making decisions.
Stock Down 2.86%
Spectral Med's market cap stands at CA$410.79 million, reflecting investor caution as the stock slides.
Bull case
If Spectral Med can successfully navigate its regulatory processes and bring its products to market, it could see a rebound in stock price and investor confidence.
Bear case
A continued lack of news and regulatory delays could further weaken investor sentiment, possibly leading to additional declines in stock value.
Advertisement
Current Performance Overview
Spectral Med Inc's stock is down 2.86% today, closing at CA$1.36. This decline is concerning for investors, especially given the company's recent lack of news that could influence stock performance. With a market cap of CA$410.79 million, the stock's movement reflects broader market sentiments and investor caution.
Market Sentiment and Future Outlook
The absence of significant announcements from Spectral Med, such as updates on its PMA application or trial results, has left investors feeling uncertain. Without fresh catalysts, the stock may continue to face downward pressure. Investors should keep an eye on developments related to the company's regulatory filings and market conditions to gauge future performance. For more information on the company's recent activities, check the latest updates on Spectral Med Inc.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
